# Real-world use and clinical outcomes among patients with atrial fibrillation using low-dose edoxaban and apixaban in Italy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-use-and-clinical-outcomes-among-patients-with-atrial-fibrillation/

## Facts

| Field | Value |
| --- | --- |
| Author Names | R W Wang,Saibal Gupta,Joseph Imperato,Alan Alejandro Guzman Valladares,Shantanu Jawla,Rüdiger Smolnik,C C Chen,Martin Unverdorben,X Ye,Bernd Brüggenjürgen,Giuseppe Patti |
| Citations | 0 |
| DOI | 10.1093/europace/euaf085.840 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://academic.oup.com/europace/article-pdf/27/Supplement_1/euaf085.840/63303117/euaf085.840.pdf |
| OpenAlex ID | https://openalex.org/W4410620885 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Joseph Imperato](https://scholariq.org/researchers/joseph-imperato/)

## Paper primary topic

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Paper topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.